The discovery supports GM1 ganglioside as a potential target for Parkinson’s therapy.
Molecule reduces accumulation of toxic protein in Parkinson’s disease model
The discovery supports GM1 ganglioside as a potential target for Parkinson’s therapy.
The discovery supports GM1 ganglioside as a potential target for Parkinson’s therapy.